Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps her Department is taking to secure supplies of hormone replacement therapy medications for (a) Liverpool and (b) England.

There are currently a limited number of supply issues for hormone replacement therapy (HRT) products where alternatives remain available in England. We are working with suppliers and the National Health Service and the Medicines and Healthcare products Regulatory Agency to maintain overall supply, including expediting resupply dates of disrupted HRT products and to fill supply gaps to prevent future shortages. Access to in-demand products has improved since Serious Shortage Protocols were issued for HRT products to limit dispensing to three months’ supply to maintain distribution and allow alternative products to be dispensed as necessary.